NEUROENDOCRINE PROSTATE CANCER (NEPC)
Clinical trials for NEUROENDOCRINE PROSTATE CANCER (NEPC) explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE PROSTATE CANCER (NEPC) trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE PROSTATE CANCER (NEPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients sought for groundbreaking engineered immune cell cancer trial
Disease control Not yet recruitingThis is the first study in people to test the safety and early effects of an experimental cell therapy called ML261. It is for adults with advanced small cell lung cancer or certain related neuroendocrine cancers that have come back or stopped responding to standard treatments. D…
Matched conditions: NEUROENDOCRINE PROSTATE CANCER (NEPC)
Phase: PHASE1 • Sponsor: Moonlight Bio, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Alzheimer's drug tested as new hope for tough prostate cancer
Disease control Not yet recruitingThis study is testing if a drug called memantine hydrochloride, commonly used for Alzheimer's disease, can help control advanced prostate cancer that has spread and stopped responding to standard hormone therapies. It will involve about 15 men who have already tried one or two ot…
Matched conditions: NEUROENDOCRINE PROSTATE CANCER (NEPC)
Phase: PHASE2 • Sponsor: Bin Xu • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC